Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

Mifepristone remains available until U.S. Supreme Court weighs in, likely next year

CONCORD, NH – Today, a three-judge panel of the Fifth Circuit Court of Appeals issued a decision in Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al, the baseless case challenging the FDA’s approval of mifepristone, a safe and effective drug used in over half of all U.S. abortions. The ruling sharply restricts abortion pill access nationwide - but it won’t take effect until the U.S. Supreme Court weighs in, likely next year. 

For now, mifepristone remains safe, legal, and available throughout the country. Planned Parenthood of Northern New England health centers in Maine, New Hampshire, and Vermont will continue to offer medication abortion using the mifepristone protocol until further notice.

For more information about this case and medication abortion, click here.

Statement from Nicole Clegg, Acting CEO, Planned Parenthood Northern New England: 

“Planned Parenthood of Northern New England continues to offer medication abortion to our patients. We have no plans to change our protocol at this time. 

Today’s ruling is the latest politically motivated attack on abortion access and reproductive health care. Anti-abortion extremists relied on junk science, cherry-picked judges to hear this case, and are intent on sowing chaos and confusion in this unprecedented assault on not only medication abortion but the Federal Drug Administration's (FDA) authority to approve medications of all kinds. 

Let’s be clear: The political actors behind this lawsuit are not concerned about patient needs or safety. They want to ban abortion, and they are using every tactic they can imagine to achieve their goal. Mifepristone is a safe, effective drug approved by the FDA more than 20 years ago, and the mifepristone/misoprostol medication abortion protocol has been the standard in the United States for years. 

Our country is in the middle of an abortion access crisis; 21 states have enacted bans or near total bans on abortion since the U.S. Supreme Court revoked federal protections in June 2022. While Maine, New Hampshire, and Vermont have resisted attempts to restrict access, it is important to remember that if the Supreme Court upholds the lower court ruling in this case, medication abortion access in every state in the country will be impacted, regardless of state laws. 

We remain committed to providing the safest, high-quality health care services to every patient who comes to us — no matter what.”  

###

Planned Parenthood of Northern New England (PPNNE) is the largest provider of reproductive and sexual health care across the State of New Hampshire. We serve New Hampshire residents through 5 health centers in Derry, Exeter, Keene, Manchester and White River Junction, VT. Last year we saw more than 10,000 patients at these sites. PPNNE was named a 2021 and 2022 Guardian of Excellence Award® winner by Press Ganey, the national leader in health care consumer and workforce engagement. Press Ganey recognizes PPNNE as a top-performing health care organization, achieving the 95th percentile or above for performance in patient experience, out of more than 20,000 medical practices

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of our Necessary Cookies as they are deployed to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information, please see our Privacy Notice.

Marketing

On

We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.

Performance

On

We use qualitative data, including session replay, to learn about your user experience and improve our products and services.

Analytics

On

We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.